The dermMentors’ Resident of Distinction Awards Program recently celebrated its 15th anniversary at the @MauiDerm Hawaii conference. Meet the Class of 2026 and get to know more about their award-winning research and their aspirations. https://t.co/ibv3bDtPqv
It was a privilege to care for her and to work alongside the incredible multidisciplinary team at @BostonChildrens
She once told me that she hoped sharing her story might help others like her receive timely diagnosis and care, and I hope this case brings us closer to that goal
An adolescent female presented with 3 days of progressive abdominal pain and reported that a rash first appeared nearly 1 year earlier on her left wrist and gradually spread over several weeks.
What is your diagnosis? https://t.co/vyT68yL7TH
An adolescent female presented with 3 days of progressive abdominal pain and reported that a rash first appeared nearly 1 year earlier on her left wrist and gradually spread over several weeks.
What is your diagnosis? https://t.co/vyT68yL7TH
New year, newly released data! This release includes our first PGS for prurigo nodularis (from @c_vasavda@drshawnkwatra@EugeneSemenovMD@SashaGusevPosts) 👉https://t.co/20gRVnyNER.
See https://t.co/1vIsTbwuHI for all the data, and https://t.co/kxG9MiSEIZ to submit your PGS!
Check out our study published today in @NEJM on #nemolizumab for #prurigo nodularis https://t.co/YZE21udRt3. The rapidity of itch reduction is a seismic finding that will send shockwaves reverberating throughout all of the itch & dermatology worlds. A huge win for itch patients!
This morning, I spoke at my alma mater to @BrighamWomens residents and faculty to talk all things medicine and public health. I wouldn’t be where I am today without the extraordinary mentors and colleagues at BWH—will always be grateful for them.
Sometimes my work puts me in touch with exceptional individuals. One of those, whom I had the pleasure of interviewing this week, is neuroscientist/psychiatrist Solomon Snyder. One of his colleagues described him to me as a "f*cking genius" and I was not disappointed 1/6
Congrats to SOCS leader + 2022 Career Development Award winner @drshawnkwatra + team on the publication of their groundbreaking work in the Journal of Investigative Dermatology, A polygenic risk score for predicting racial and genetic susceptibilit...https://t.co/iZIwR4AvcH
Please check our latest paper https://t.co/z1MuEc1jol. LSD and psilocin are high-affinity ligands of TrkB, sensitizing TrkB to BDNF, promoting plasticity, but not hallucinations. Huge thanks to all the co-authors, especially @RafaelMoliner, @p_casarotto and Ilpo Vattulainen.
Check out our recent study showing a nearly two-fold increased risk of incident aortic valve calcification among those with elevated lipoprotein(a) and hsCRP. https://t.co/wikd5E37P2
#ACCprev#ACC#CardioTwitter#JACCIMG#AorticDisease@rblument1
bilirubin demonstrating some hormesis with NMDA neurotransmission - attenuating NMDA redox signaling as we've shown vs potentiating excitotoxicity at pathologic concentrations as reported here.
another awesome case study in tight control of metabolism
https://t.co/2aACSIsNzY
Excited to share our work on an improved method for detecting off-target CRISPR-Cas genome editing, published in @naturemethods! A fun and collaborative study from my time @taekjip lab, building on seminal work on off-target detection @jcornlab, a 🧵:
https://t.co/q1BNOK3mgG
1/ Do anti-anxiety
drugs influence cancer patient survival? To find out, read the new @TheFeiginLab
@medrxivpreprint, “Lorazepam stimulates IL-6 production and is associated with
poor survival outcomes in pancreatic cancer.” https://t.co/nUbDI2dLVA. Summary thread below (1/12):